While transgenic mouse models such as Tg2576 provide valuable insight into amyloid-associated molecular mechanisms, they do not recapitulate the full spectrum of human AD pathology, including tau pathology, neurodegeneration and cognitive heterogeneity. This evidence concerns the gene MAPT and Alzheimer disease.